ArticleCell death discovery2026
Aluminium ammonium sulphate induces epithelial pyroptosis and eosinophilic inflammation under dysbiotic conditions: ameliorative effects of heparin.
Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Aluminium ammonium sulphate (AAS) is a food additive used in some countries, but its effects on intestinal epithelial cells (IECs) remain poorly understood. We investigated whether AAS promotes IEC death and eosinophilic infiltration under dysbiotic conditions and whether heparin suppresses these effects. Mice pretreated with antibiotics or control water were orally administered AAS. IEC death was assessed by RNA sequencing, western blotting, and flow cytometry. Microbiota composition was analysed by 16S rRNA sequencing, and eosinophilic infiltration was evaluated by histology and flow cytometry. Immortalised murine IECs were stimulated with AAS in the presence or absence of bacterial components, and the effects of heparin were examined in vitro and in vivo. Antibiotic-induced dysbiosis altered IEC metabolic programmes and reduced polysaccharide-degrading bacteria. Under these conditions, AAS further reduced Actinobacteria, including Bifidobacterium, increased mitochondrial reactive oxygen species (mtROS), and promoted cleavage of caspase-1, caspase-6, caspase-8, caspase-11, interleukin-33, gasdermin D (GSDMD), and gasdermin E (GSDME) in IECs. These changes were associated with epithelial pyroptosis and eosinophilic infiltration in the small intestine. AAS induced similar cleavage events in IECs primed with lipopolysaccharide and lipoteichoic acid in vitro. Antioxidant studies showed that caspase-1/11-GSDMD activation was ROS-dependent, whereas caspase-6/8-GSDME activation involved ROS-independent mechanisms. Heparin suppressed these cleavage events, reduced IEC death both in vitro and in vivo, and attenuated eosinophilic inflammation. These findings identify a previously unrecognised pro-inflammatory effect of AAS in the dysbiotic gut and suggest low-dose heparin as a potential protective strategy for intestinal epithelial homoeostasis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.